Top

Published in:

Open Access 01-04-2011

Imaging as an End Point in Ischemia Trials

Authors: Andrew G. Howarth, Matthias G. Friedrich

Published in: Current Cardiovascular Imaging Reports | Issue 2/2011

Abstract

Imaging of cardiac function and anatomy has advanced at an exponential rate over the past two decades. Our ability to quantitatively assess the degree of myocardial ischemia and accurately define the vascular anatomy using noninvasive techniques is greater than ever before. Current advances is cardiac imaging are allowing us to more safely assess patients for myocardial ischemia and better understand the prognostic implications of our findings. This review summarizes the current state of knowledge in cardiac imaging for the assessment of cardiac ischemia with a focus on the use of cardiac MRI.

Emond M, Mock MB, Davis KB, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation, 1994:2645–57.

Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900–7.PubMedCrossRef

Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med, 2007:1503–16.

Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation, 2008:1283–91.

Simoons ML, Windecker S. Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization. European heart journal 2010;31:530–41.PubMedCrossRef

• Tonino P, Fearon W, De Bruyne B, et al. Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation. Journal of the American College of Cardiology, 2010:2816–2821. This is an important contribution that reinforces the concept of difference between functional ischemia and angiographic appearance of a stenosis.

Shaw L. Prognostic value of gated myocardial perfusion SPECT. Journal of Nuclear Cardiology, 2004:171–185.

Marwick T, Shan K, Patel S, Go RT, Lauer MS. Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease. Am J Cardiol 1997;80:6.CrossRef

• Schwitter J, Wacker C, Van Rossum A, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. European heart journal, 2008:480. This is the first multicenter trial comparing the diagnostic performance of stress perfusion CMR to SPECT.

10.

•• Hamon M, Fau G, Née G, Ehtisham J, Morello R, Hamon M. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. JCMR 2010;12:10. Meta-analysis providing up-to-date data on the diagnostic performance of CMR as reported over multiple recent trials.

11.

Pilz g, Klos M, Ali E, Hoefling B, Scheck R, Bernhardt P. Angiographic correlations of patients with small vessel disease diagnosed by adenosine stress cardiac magnetic resonance imaging. JCMR 2008; 10:8.

12.

Jahnke C, Nagel E, Gebker R, et al. Prognostic Value of Cardiac Magnetic Resonance Stress Tests: Adenosine Stress Perfusion and Dobutamine Stress Wall Motion Imaging. Circulation, 2007:1769–1776.

13.

Lerakis S, McLean D, Anadiotis A, et al. Prognostic value of adenosine stress cardiovascular magnetic resonance in patients with low-risk chest pain. Journal of Cardiovascular Magnetic Resonance, 2009:37.

14.

Spuentrup E, Ruhl KM, Botnar RM, et al. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model. Circulation, 2009:1768–75.

15.

• Kurita T, Sakuma H, Onishi K, et al. Regional myocardial perfusion reserve determined using myocardial perfusion magnetic resonance imaging showed a direct correlation with coronary flow velocity reserve by Doppler flow wire. European heart journal, 2008. This is an elegant study comparing Doppler flow wire measurements at cardiac catheterization with CMR perfusion.

16.

Watkins S, McGeoch R, Lyne J, et al. Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease. Circulation, 2009:2207–13.

17.

•• Patel A, Antkowiak P, Nandalur K, et al. Assessment of Advanced Coronary Artery Disease: Advantages of Quantitative Cardiac Magnetic Resonance Perfusion Analysis. Journal of the American College of Cardiology, 2010:561. A systematic look at the additional information obtained when performing quantitative perfusion analysis of CMR stress perfusion as compared to subjective evaluation. A persuasive argument in favor of quantitative studies.

18.

Kim R. Viability Assessment by Delayed Enhancement Cardiovascular Magnetic Resonance: Will Low-Dose Dobutamine Dull the Shine? Circulation 2004;109:2476–2479.PubMedCrossRef

19.

Simonetti OP, Kim, R.J., Fieno, D.S., Hillenbrand, H.B., Wu, E., Bundy, J.M., Finn, J.P., Judd, R.M. . An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:8.

20.

Plein S, Younger J, Sparrow P, Ridgway J, Ball S, Greenwood J. Cardiovascular magnetic resonance of scar and ischemia burden early after acute ST elevation and non-ST elevation myocardial infarction. Journal of Cardiovascular Magnetic Resonance, 2008:47.

21.

• Steel K, Broderick R, Gandla V, et al. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation, 2009:1390. This article presents data supporting the combination of stress perfusion with late enhancement analysis. Techniques are shown to provide independent prognostic information.

22.

Heinz-Peer G, Neruda A, Watschinger B, et al. Prevalence of NSF following intravenous gadolinium-contrast media administration in dialysis patients with endstage renal disease. Eur J Radiol;76:129–34.

23.

Thomsen HS, Morcos SK, Dawson P. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)? Clin Radiol 2006;61:905–6.PubMedCrossRef

24.

• Wang D, Bi X, Avants B, Meng T. Estimation of perfusion and arterial transit time in myocardium using free-breathing myocardial arterial spin labeling with navigator-echo. Magnetic Resonance in Medicine 2010;64:1289–95. Technical paper advances flow imaging of the coronary arteries.

25.

• Karamitsos T, Leccisotti L, Arnold J, et al. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography. Circulation: Cardiovascular Imaging, 2009. This well-done study compares PET coronary flow data with BOLD myocardial oxygenation data. It presents evidence suggesting that limitation of myocardial blood supply does not equate to myocardial ischemia.

26.

Friedrich MG. Testing for myocardial ischemia: the end of surrogates? JACC Cardiovasc Imaging 2010;3:385–7.PubMedCrossRef

27.

Vohringer M, Flewitt JA, Green JD, et al. Oxygenation-sensitive CMR for assessing vasodilator-induced changes of myocardial oxygenation. J Cardiovasc Magn Reson 2010;12:20.PubMedCrossRef

28.

• McCommis K, Goldstein T, Abendschein D, et al. Quantification of regional myocardial oxygenation by magnetic resonance imaging: validation with positron emission tomography. Circulation: Cardiovascular Imaging, 2009. This proof-of-concept BOLD imaging paper compares PET flow data with BOLD oxygenation imaging in a large animal model.

29.

• Manka R, Paetsch I, Schnackenburg B. BOLD cardiovascular magnetic resonance at 3. 0 tesla in myocardial ischemia. J. Cardiovasc Magn Reson 2010;12:54. BOLD imaging at 3.0 T is shown to be clinically feasible.

30.

•• Jahnke C, Gebker R, Manka R, Schnackenburg B, Fleck E, Paetsch I. Navigator-gated 3D blood oxygen level-dependent CMR at 3.0-T for detection of stress-induced myocardial ischemic reactions. JACC Cardiovasc Imaging 2010;3:375–84. BOLD imaging at 3.0 T is shown to be clinically feasible; compares stress-rest perfusion to BOLD and angiographic results. PubMedCrossRef

31.

Yao SS, Qureshi, E., Sherrid, M.V., Chaudhry, F.A., . Practical applications in stress echocardiography: risk stratification and prognosis in patients with known or suspected ischemic heart disease. J Am Coll Cardiol 2003;42:6.CrossRef

32.

Korosoglou G, Elhmidi Y, Steen H, et al. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. J Am Coll Cardiol, 2010:1225–34.

33.

Budoff MJ, Diamond GA, Raggi P, et al. Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation 2002;105:1791–6.CrossRef

34.

Rozanski A, Gransar H, Wong ND, et al. Clinical outcomes after both coronary calcium scanning and exercise myocardial perfusion scintigraphy. J Am Coll Cardiol 2007;49:1352–61.PubMedCrossRef

35.

Adamu U, Knollmann D, Almutairi B, et al. Stress/rest myocardial perfusion scintigraphy in patients without significant coronary artery disease. Journal of Nuclear Cardiology, 2010:38–44.

36.

Russo V, Zavalloni A, Bacchi Reggiani ML, et al. Incremental Prognostic Value of Coronary CT Angiography in Patients With Suspected Coronary Artery Disease. Circulation: Cardiovascular Imaging 2010;3:351–359.CrossRef

37.

Kim WY. Three-Dimensional Black-Blood Cardiac Magnetic Resonance Coronary Vessel Wall Imaging Detects Positive Arterial Remodeling in Patients With Nonsignificant Coronary Artery Disease. Circulation 2002;106:296–299.PubMedCrossRef

38.

Kim WY, Astrup AS, Stuber M, et al. Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation 2007;115:228–35.PubMedCrossRef

39.

Abd-Elmoniem KZ, Weiss RG, Stuber M. Phase-sensitive black-blood coronary vessel wall imaging. Magn Reson Med, 2010:1021–30.

40.

Morishige K, Kacher DF, Libby P, et al. High-Resolution Magnetic Resonance Imaging Enhanced With Superparamagnetic Nanoparticles Measures Macrophage Burden in Atherosclerosis. Circulation, 2010:1–10.

41.

Libby P. Inflammation and Atherosclerosis. Circulation, 2002:1135–1143.

Title: Imaging as an End Point in Ischemia Trials
Authors: Andrew G. Howarth
Matthias G. Friedrich
Publication date: 01-04-2011
Publisher: Current Science Inc.
Published in: Current Cardiovascular Imaging Reports / Issue 2/2011
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI: https://doi.org/10.1007/s12410-011-9068-6

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Imaging as an End Point in Ischemia Trials

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2011

CMR for Assessment of Diastolic Function

Coronary MRA: Technical Advances and Clinical Applications

Myocardial Oxygenation Imaging: New Methods for Ischemia Detection

Measuring Treatment Effects in Clinical Trials Using Cardiac MRI

Toward Full Quantification of Wall Motion with MRI

Does Late Enhancement Imaging Decipher the Role of Myocardial Fibrosis in Hypertrophic Cardiomyopathy?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page